These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29900681)

  • 1. Envisioning the future of polymer therapeutics for brain disorders.
    Rodriguez-Otormin F; Duro-Castano A; Conejos-Sánchez I; Vicent MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1532. PubMed ID: 29900681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Targeting of siRNA via Intranasal Pathway.
    Mohanty C; Kundu P; Sahoo SK
    Curr Pharm Des; 2015; 21(31):4606-13. PubMed ID: 26486146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications.
    Yang J; Luly KM; Green JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1853. PubMed ID: 36193561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
    Jiang Y; Li Y; Liu X
    Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules.
    Grigoletto A; Tedeschini T; Canato E; Pasut G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1689. PubMed ID: 33314717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders.
    Sharma A; Manchanda R; Pottoo FH; Ashraf GM
    Curr Drug Metab; 2021; 22(4):251-262. PubMed ID: 33234099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting specific cells in the brain with nanomedicines for CNS therapies.
    Zhang F; Lin YA; Kannan S; Kannan RM
    J Control Release; 2016 Oct; 240():212-226. PubMed ID: 26686078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.
    Duncan R
    J Drug Target; 2017; 25(9-10):759-780. PubMed ID: 28783978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-drug conjugates: recent progress on administration routes.
    Pang X; Yang X; Zhai G
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1075-86. PubMed ID: 24758250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal delivery to the central nervous system: mechanisms and experimental considerations.
    Dhuria SV; Hanson LR; Frey WH
    J Pharm Sci; 2010 Apr; 99(4):1654-73. PubMed ID: 19877171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel central nervous system drug delivery systems.
    Stockwell J; Abdi N; Lu X; Maheshwari O; Taghibiglou C
    Chem Biol Drug Des; 2014 May; 83(5):507-20. PubMed ID: 24325540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective.
    Soni S; Ruhela RK; Medhi B
    Adv Pharm Bull; 2016 Sep; 6(3):319-335. PubMed ID: 27766216
    [No Abstract]   [Full Text] [Related]  

  • 19. Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System.
    Spencer AP; Torrado M; Custódio B; Silva-Reis SC; Santos SD; Leiro V; Pêgo AP
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32102252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases.
    Cano A; Sánchez-López E; Ettcheto M; López-Machado A; Espina M; Souto EB; Galindo R; Camins A; García ML; Turowski P
    Nanomedicine (Lond); 2020 May; 15(12):1239-1261. PubMed ID: 32370600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.